Chiral Technology Market to Reach $5.6 Billion in 2012 According to New Report by Global Industry Analysts Inc.



The fast developing small molecule chiral technology sector is witnessing a flurry of activity with pharmaceutical companies adding chiral expertise to their portfolios. Several leading pharmaceuticals such as Lipitor, Zocor, Advair, Norvasc and Viagra are chiral based. While conventional processes of chiral production such as resolution and chiral pool chemistry are time-tested methods, emerging asymmetric and biological methods are also the focus of attention, garnering significant research dollars. Over the past few years, technological progress has had a growing influence on pharmaceutical research and development - almost 90% of all drugs in the pipeline are chiral based. Pharmaceuticals is expected to remain the largest industry for chiral technology in the near future.

European market for chiral technology enabling products, the largest worldwide, is estimated at $1.9 billion for 2008 as stated by Global Industry Analysts, Inc. United States represents the second largest regional market. The US and Europe together account for over 85% of the global market for chiral technology enabling products (http://www.strategyr.com/Chiral_Technology_Market_Report.asp). Chiral intermediates market (http://www.strategyr.com/Chiral_Technology_Market_Report.asp) worldwide is estimated at US$3.5 billion for 2008. US Market for chiral analytical products (http://www.strategyr.com/Chiral_Technology_Market_Report.asp) is expected to record a CAGR of close to 7.5% over the period 2000-2010. End-use markets including pharmaceuticals and agrochemicals are projected to register compounded annual growth rates of approximately 9% and 6.5% respectively over the period 2000-2010.

The global marketplace includes participants such as Albemarle, BASF, Cambrex, Chiral Quest, Dalco ChromTech, Daicel Chemical, DSM Pharma, DowpharmaSM, Johnson Matthey, Regis Technologies, Shasun Chemicals and Drugs, Solvias, Sigma Aldrich and Suven Life Sciences.

"Chiral Technology: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market trends and issues, drivers, technology profile, end-use perspective, players, competition, technological developments, new product introductions, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major geographic markets such as United States, Japan and Europe for the period 2000-2015. Analytics are provided for Chiral Technology Enabling Products by product segments including chiral intermediates, chiral analytical products, and others. The study also analyzes end-use markets including Pharmaceuticals and Agrochemicals.

For more details about this research report, please visit http://www.strategyr.com/Chiral_Technology_Market_Report.asp.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) (http://www.strategyr.com) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.

Telephone 408-528-9966

Fax 408-528-9977

Email press @ StrategyR.com

Web Site www.StrategyR.com





Chiral Technology Market to Reach $5.6 Billion in 2012 According to New Report by Global Industry Analysts Inc.